Aktiespot

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHANGHAI SHENQI PHARM INVEST MA) Aktie

600613.SS

¥5.28+0.13 (+2.52%)
Chart wird geladen...

SHANGHAI SHENQI PHARM INVEST MA

Eröffnung5.16
Hoch5.31
Tief5.10
Volumen7.5M
P/E88.00
Marktkapitalisierung2.82B
52-Wochen-Hoch7.53
52-Wochen-Tief5.05
Durchschn. Volumen13.31M
Dividende2.84%
BetaN/A
EPS0.06

Über Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHANGHAI SHENQI PHARM INVEST MA) Aktie

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.

Unternehmensinformationen

Börse: Shanghai (SHH)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Generelt
Adresse:
Changfa Building
200003 Shanghai, China

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: